← Back to Clinical Trials
Recruiting NCT07523854

NCT07523854 Effect of Graft Type on Knee Muscle Strength After ACL Reconstruction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07523854
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Anterior Cruciate Ligament Reconstruction Rehabilitation
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2026-01-23
Primary Completion 2027-01-25

Trial Parameters

Condition Anterior Cruciate Ligament Reconstruction Rehabilitation
Sponsor Hacettepe University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 13 Years
Max Age 45 Years
Start Date 2026-01-23
Completion 2027-01-25

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This prospective observational study will compare recovery after anterior cruciate ligament reconstruction using quadriceps tendon autograft or hamstring tendon autograft. The main goal is to examine differences in knee muscle strength recovery during the early and mid-term postoperative period. Participants aged 13 to 45 years who undergo unilateral ACL reconstruction and meet the eligibility criteria will be followed at Hacettepe University. Knee extensor and flexor strength will be assessed using isometric testing at postoperative weeks 4, 8, and 12 and month 6, and with isokinetic concentric testing at months 3 and 6. Functional outcomes and kinesiophobia will also be evaluated at month 6 using IKDC, KOOS, and the Tampa Scale for Kinesiophobia. All participants will receive the same standard postoperative rehabilitation program under physiotherapist supervision. The study aims to clarify whether graft type is associated with different patterns of muscle strength recovery and functional improvement after ACL reconstruction

Eligibility Criteria

Inclusion Criteria: * Age 13 to 45 years * Undergoing anterior cruciate ligament reconstruction with either hamstring tendon autograft or quadriceps tendon autograft * Unilateral anterior cruciate ligament injury * Complete ACL tear with accompanying minimal collateral ligament injury and first-degree meniscal tear * Tegner Activity Score of 5 or higher * Willingness to participate in the study Exclusion Criteria: * Anterior cruciate ligament reconstruction with patellar tendon autograft or allograft * Revision surgery * Systemic or neurological disease * Multiple ligament injuries * Grade III lateral or medial collateral ligament tear or significant articular cartilage lesion * Failure to regularly attend the rehabilitation program during the first 3 postoperative months * History of lower extremity injury in the contralateral limb within the last 12 months * Hypertension, cardiovascular disease, peripheral vascular disease, history of deep vein thrombosis, neurological disease, syste

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology